TKNOAlpha Teknova, Inc.
$8.45+61% 1Y
$8.45
$1.9952 weeks$9.34
Is the price fair?
What TKNO's price assumes
Alpha Teknova, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.71× revenue.
3.71
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.39
Price / book · as of 2026-Q1
- EV / sales
- 4.27
EV / sales
Details›
- Price / bookas of 2026-Q1
- 2.39
- EV / EBIToperating margin −36%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 4.27
- Market capitalisation
- $453M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #27 of 41 by RyuScore